Cas:914349-23-8 tert-butyl 3,5-dibromoindole-1-carboxylate manufacturer & supplier

We serve Chemical Name:tert-butyl 3,5-dibromoindole-1-carboxylate CAS:914349-23-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl 3,5-dibromoindole-1-carboxylate

Chemical Name:tert-butyl 3,5-dibromoindole-1-carboxylate
CAS.NO:914349-23-8
Synonyms:1-Boc-3,5-Dibromoindole;OR1708
Molecular Formula:C13H13Br2NO2
Molecular Weight:375.05600
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:414.5ºC at 760 mmHg
Density:1.64g/cm3
Index of Refraction:1.608
PSA:31.23000
Exact Mass:372.93100
LogP:4.94950

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Boc-3,5-Dibromoindole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,OR1708 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Boc-3,5-Dibromoindole Use and application,1-Boc-3,5-Dibromoindole technical grade,usp/ep/jp grade.


Related News: This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. tert-butyl 3,5-dibromoindole-1-carboxylate manufacturer Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country. tert-butyl 3,5-dibromoindole-1-carboxylate supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. tert-butyl 3,5-dibromoindole-1-carboxylate vendor Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. tert-butyl 3,5-dibromoindole-1-carboxylate factory Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country.